Ivan Diaz-padilla MD, PhD

Ivan Diaz-Padilla, M.D., Ph.D. is board-certified in Medical Oncology by the Spanish Ministry of Health. He completed a clinical research fellowship in Gynecologic Oncology and Drug Development at the Princess Margaret Cancer Center in Toronto, Canada, and obtained his PhD from the University of Seville, Spain, for his research on Notch inhibition in ovarian cancer. Dr. Diaz-Padilla has practiced in several international academic settings for around 10 years before joining the pharmaceutical industry. He currently works as Medical Director in the Global Clinical Development department of Novartis Oncology, headquartered in Basel, Switzerland.